来凯医药-B(02105)根据2024年股份奖励计划发行合计273万股普通股

Core Viewpoint - 来凯医药-B (02105) announced the issuance of a total of 2.73 million ordinary shares on September 5, 2025, to fulfill the vesting of RSUs granted under the 2024 share incentive plan [1] Summary by Relevant Categories - Company Actions - The company will issue 2.73 million ordinary shares [1] - This issuance is part of the 2024 share incentive plan [1] - Future Plans - The shares will be issued on September 5, 2025 [1]